Combined inhibition of DDR1 and CDK4/6 induces synergistic effects in ER-positive, HER2-negative breast cancer with PIK3CA/AKT1 mutations
Maryam Shariati, Kurt W. Evans, Xiaofeng Zheng, Christopher A. Bristow, Patrick Kwok‐Shing Ng, Yasmeen Q. Rizvi, Coya Tapia, Fei Yang, Alessandro Carugo, Timothy P. Heffernan, Michael Peoples, Debu Tripathy, Funda Meric‐Bernstam
Topics & Concepts
BiologyAKT1Cancer researchBreast cancerCancerMutationGeneticsGeneInternal medicineSignal transductionPI3K/AKT/mTOR pathwayMedicineAdvanced Breast Cancer TherapiesCancer-related Molecular PathwaysChronic Lymphocytic Leukemia Research